<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    Anixa Biosciences, Inc.

    Anixa Biosciences, Inc.

    Anixa is focused on harnessing the body’s immune system in the fight against can...

    Anixa is focused on harnessing the body’s imm...

    Filing Type:    PU
    Graphic Armor, Inc.

    Graphic Armor, Inc.

    Graphic Armor develops and sells condoms with unique designs called Tattoo Condoms...

    Graphic Armor develops and sells condoms with u...

    Filing Type:    CF
    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on ...

    Bellicum Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Gamida Cell Ltd.

    Gamida Cell Ltd.

    Gamida Cell is a clinical-stage biopharmaceutical company committed to developing ...

    Gamida Cell is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Akorn, Inc.

    Akorn, Inc.

    Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and mark...

    Akorn, Inc. is a niche pharmaceutical company t...

    Filing Type:    PU
    Cellectar Biosciences, Inc.

    Cellectar Biosciences, Inc.

    We are a clinical stage biopharmaceutical company focused on the discovery, develo...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Fate Therapeutics, Inc.

    Fate Therapeutics, Inc.

    We are a biopharmaceutical company dedicated to the development of programmed cell...

    We are a biopharmaceutical company dedicated to...

    Filing Type:    PU
    Jazz Pharmaceuticals plc

    Jazz Pharmaceuticals plc

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company that...

    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a gl...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.